GSK strengthens pulmonary hypertension pipeline with USD950m acquisition of 35Pharma

Mestag Therapeutics to present targeted LTBR agonist MST-0312 at AACR Annual Meeting

Trellus Health renews licensing agreement with Pfizer

EU approves Sanofi and Regeneron's Dupixent for young children with chronic spontaneous urticaria

GSK secures China approval for Exdensur to treat nasal polyp condition

Insmed reports Phase 2b study of brensocatib did not meet efficacy endpoints

Alloy Therapeutics and Biogen expand partnership with multi-target antisense collaboration

Parnell launches first FDA-approved generic florfenicol and flunixin combination for bovine respiratory disease

Innovent and Ollin Biosciences report IBI324 study data in wAMD and DME

Boston Scientific receives FDA clearance for Asurys fluid management system

Lilly presents Phase 3b Taltz (ixekizumab) plus Zepbound (tirzepatide) data at AAD Annual Meeting

Hoth Therapeutics deploys OpenClaw AI platform for drug discovery

Thermo Fisher Scientific and SHL Medical launch integrated US drug-device manufacturing

Sanofi and Regeneron's Dupixent gains Japan approval as first targeted therapy for bullous pemphigoid

Rhythm Pharmaceuticals selects PANTHERx Rare as exclusive US distribution partner for IMCIVREE expanded indication